The only available in vivo study at the time this study was planned showed that the TRPA1 activators ASP 7663 and optovin applied before ischemia reduced infarct size in a rat model of acute myocardial infarction with 30 min ischemia followed by 2 h reperfusion [15]. The gene discussed is TRPA1; the disease is ischemia.